7
Participants
Start Date
November 14, 2022
Primary Completion Date
August 23, 2024
Study Completion Date
March 5, 2025
Macitentan
Macitentan will be administered orally as a tablet.
Nagano Children's Hospital, Azumino-shi
Institute of Science Tokyo Hospital, Bunkyō City
Fukuoka Children's Hospital, Fukuoka
Okayama University Hospital, Okayama
Toho University Medical Center Omori Hospital, Ōta-ku
Hokkaido University Hospital, Sapporo
National Center for Child Health and Development, Setagaya Ku
Tokyo Women's Medical University Hospital, Shinjuku-ku
National Cerebral and Cardiovascular Center, Suita-Shi
Osaka University Hospital, Suita-shi
The University of Tokyo Hospital, Tokyo
Lead Sponsor
Janssen Pharmaceutical K.K.
INDUSTRY